LIÊN KẾT WEBSITE
The current update of vaccines for SARS-COV-2
Electronic Journal of General Medicine Số 5, năm 2020 (Tập 17, trang -)
DOI: 10.29333/ejgm/8233
Tài liệu thuộc danh mục: Scopus
English
English
Từ khóa: adenovirus vector; angiotensin converting enzyme 2; DNA vaccine; Ebola vaccine; live vaccine; nanoparticle; nucleocapsid protein; severe acute respiratory syndrome vaccine; toll like receptor 3; toll like receptor 7; toll like receptor 8; toll like receptor 9; virus antigen; virus envelope protein; virus spike protein; Article; coronavirus disease 2019; DNA immunization; drug development; human; immune response; immune system; immunization; influenza; mucosal immunity; nonhuman; protein motif; receptor binding; Severe acute respiratory syndrome coronavirus 2; T lymphocyte activation; vaccination; vaccine immunogenicity; virion; virus attachment; virus entry; virus genome; wellbeing
Tóm tắt tiếng anh
Late 2019 witnessed the appearance of coronavirus disease 2019 (COVID-19) outbreak triggered by a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 spread across China from Wuhan and has been circulated to a broader variety of countries. Seeing that COVID-19 has caused tremendous human casualties posing a global danger, an awareness of the current situation and the strategies to curtail the spread of the virus are desperately required. As the most natural way to preserve public wellbeing, preventive and therapeutic vaccinations must have essential roles. Large organizations and companies have started implementing SARS-CoV-2 preventive vaccinations. Hence, in this study, we aimed to update the vaccine evolution for SARS-CoV-2. � 2020 by Author/s and Licensed by Modestum Ltd., UK.
